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ABSTRACT
Host genetic factors play an important role in mediating resistance to HIV-1 infection and may 
modify the course of infection. HLA-B alleles (Bw4 epitope; B*27 and B*57) as well as killer cell 
immunoglobulin-like receptors have been associated with slow progression of HIV-1 infection. 
Objective: To evaluate the association between serological epitopes HLA-Bw4 and HLA-Bw6 and 
prognostic markers in AIDS. Methods: 147 HIV-infected individuals in Bahia, Northeast Brazil, 
were genotyped for HLA class I locus. HLA class I genotyping was performed by hybridization with 
sequence-specifi c oligonucleotide probes following amplifi cation of the corresponding HLA-A, 
HLA-B and HLA-C genes. Statistical analysis was performed using Fisher´s exact and ANOVA tests 
for categorical and continuous variables, respectively. Results: We detected a signifi cant association 
(χ2 = 4.856; p = 0.018) between the presence of HLA-Bw4 and low levels of viremia. Eighteen out of 
the 147 HIV-infected individuals presented viremia  1,800 copies/mL and 129 presented viremia 
> 2,000 copies/mL. Ninety and four percent (17/18) of all individuals with viremia  1,800 copies/
mL carried HLA-Bw4, compared to 67.4% (87/129) of individuals with viremia > 2,000 copies/mL. 
Additionally, we found a signifi cantly higher frequency of B*57 (OR = 13.94; 95% CI = 4.19-46.38; p 
< 0.0001) and Cw*18 (OR = 16.15; 95% CI = 3.46-75.43; p ≤ 0.0001) alleles, favoring the group with 
lower viremia levels, in comparison with those with higher viral load. Conclusion: HLA-Bw4-B*57 
and Cw*18 alleles are associated with lower level of viral load in HIV-infected Brazilian patients. 
These fi ndings may help us in understanding the determinants of HIV evolution in Brazilian pa-
tients, as well as in providing important information on immune response correlates of protection 
for such population.
Keywords: HIV, AIDS, MHC, HLA, polymorphism.
[Braz J Infect Dis 2010;14(5):468-475]©Elsevier Editora Ltda.
INTRODUCTION
The dynamics of HIV-1 replication is a very 
important factor in determining the clinical 
course of HIV-1 disease. Although an enhanced 
production of virus particles results in progres-
sive deterioration of the immune system in 
most HIV-1 infected individuals, the control of 
viremia and the rate of progression of HIV-1 
disease have been demonstrated to be substan-
tially inﬂ uenced by host genetic characteristics.
The genetic profile of human leukocyte 
antigen (HLA) class I molecules plays a very 
important role in both, the innate and adap-
tative immune responses during the course 
of HIV-1 infection. Cytotoxic T lymphocyte 
(CTL) response depends on the recogni-
tion of viral peptides presented in associa-
tion with major histocompatibility (MHC) 
class I molecules on the surface of infected 
cells.1 Certain types of HLA-B alleles, es-
pecially B*27 and B*57, seems to strongly 
influence AIDS progression.2-6 HIV-specific 
CTL play a central role in the initial control 
of virus replication during primary HIV 
infection, when the immunologic response 
limits the viral replication and reduces the 
viremia and the number of infected cells in 
lymph nodes,7-10 as well as during chronic 
HIV infection, since the high number of 
HIV-specific CTL often persists in late in-
fection in peripheral blood of HIV-infected 
patients.11,12 Several studies reported that in 
HIV-infected long-term survivors the viral 
load and the number of CD4+ T cells in-
fected with HIV-1 are very low, and a strong 
HIV-specific CTL response is detected dur-
ing the course of infection.13,14
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The HLA repertoire can be implicated in the innate im-
munity responses. HLA class I molecules have been identi-
fi ed as killer immunoglobulin receptor (KIR) ligands.15,16 
In particular, all HLA-B specifi cities are grouped in two an-
tigenic families: HLA-Bw4 and HLA-Bw6.17 HLA-Bw4 and 
HLA-Bw6 epitopes consist of a single epitope in each HLA-B 
molecule and they are different from the epitopes that estab-
lish the HLA-B specifi city; therefore each HLA-B molecule 
expresses only one of the serological epitopes HLA-Bw4 or 
HLA-Bw6. HLA-Bw4 is one of the inhibitory or activating 
ligands for KIR18,19 that control the natural killer (NK) cell 
cytotoxic activity. As a component of the innate immune sys-
tem NK cells might have a very important role in the defense 
of the HIV-1 infected host,20 possibly controlling the viremia 
through lysis of HIV-infected cells.21,22 Genetic association 
studies and functional assays report the importance of HLA-
Bw4 in the pathogenesis of AIDS. Two studies have shown the 
protective role of HLA-Bw4 against HIV-disease progression 
through association with viremia control and CD4+ T cell 
count maintenance.21,23 Qi et al24 reported the synergistic role 
of KIR3DS1/Bw4-80Ile against CD4+ T cell depletion and de-
velopment of opportunistic infections. A more recent study 
has demonstrated that the presence of HLA-Bw4 is associated 
with a decreased risk in male-to-female HIV-1 transmission.25 
The objective of this study was to evaluate the association be-
tween serological epitopes HLA-Bw4 and HLA-Bw6 and the 
modulation of viral load and CD4+ T cell count in the Brazil-
ian HIV-infected patients.
MATERIAL AND METHODS
Subjects
Were evaluated 147 HIV-infected individuals, selected from 
an AIDS cohort established at the Hospital Universitário 
Professor Edgard Santos (HUPES) and Centro de Referên-
cia Estadual de AIDS (CREAIDS) in 1997 with HIV positive 
patients from the state of Bahia, Northeast Brazil. All the pa-
tients had a Western Blot-confi rmed HIV-1 infection. The 
cohort was monitored for CD4+ and CD8+ T cell count (cells/
mm3) and plasma viral load (copies/mL) every six months. 
The demographic and clinical parameters of all patients are 
summarized in Table 1. In Bahia state, there is a great ge-
netic mixture of Portuguese and African descendents.26-28 
Informed consent for blood donation and for genetic pol-
ymorphism investigation was obtained from each patient. 
This study was approved by the Comitê de Ética em Pesquisa 
do Centro de Pesquisa Gonçalo Moniz, Process # 29/2003.
A subset of the patients (18 individuals) was classifi ed as 
viremia controllers, in accordance with the HIV Controller 
Consortium.29 All controllers had been infected for more than 
two years, remained asymptomatic during the follow up with-
out antiretroviral therapy and maintained the viral load ≤ 1,800 
copies/mL. The patients that did not attained to all these crite-
ria (129 individuals) were classifi ed as viremia non-controllers.
HLA and KIR genotyping
Genomic DNA was extracted from whole blood using ex-
traction method GFXTM Kits Genomic Blood DNA Purifi -
cation (Amersham Pharmacia Biotech, UK). HLA genotyp-
ing was performed by using SSO LABType(R) method (ONE 
LAMBDA, Inc., Canoga Park, USA) according to the manu-
facturer’s instructions. Brieﬂ y, the polymerase chain reac-
tion (PCR) conditions were: 96oC for 3 minutes, followed by 
5 cycles of 96oC for 20 seconds, 60oC for 20 seconds and 
72oC for 20 seconds, and 30 cycles of 96oC for 10 seconds, 
60oC for 15 seconds and 72oC for 20 seconds, and extend 
at 72oC for 10 minutes. After amplifi cation of genomic 
DNA using locus-specifi c primers that ﬂ anked exon two 
and three, PCR products were denatured and annealed to 
sequence-specifi c oligonucleotide (SSO) probes of the cor-
responding HLA-A, -B and -C genes. The ﬂ uorescent inten-
sity of binding probes was identifi ed by LABScanTM100 ﬂ ow 
analyzer and the results were interpreted using HLA-visual 
software that established the HLA genotyping. HLA-A and 
HLA-B alleles were pooled HLA-Bw4 and HLA-Bw6 ac-
cording to HLA class I sequence alignments30 (Table 2). 
KIR3DS1 and KIR3DL1 genotyping was performed by us-
ing gene-specifi c primer pairs according to Martin et al.21 
Each reaction contained 15 ng of DNA, 0.1 mM DNTPs, 1.5 
mM MgCl2, 67 mM Tris-HCl (pH 8.8), 16 mM (NH4)2SO4, 
0.25 mM of each primer, and 1U of Taq polymerase in a 
10 µL fi nal volume. To improve the reliability of the results, 
besides the utilization of an internal control, all negative re-
actions were repeated to confi rm non-amplifi cation in the 
PCR. In addition, positive results were randomly replicated. 
Phenotype frequencies (f) for the presence of each gene were 
estimated by direct counting.
Table 1. Demographic and clinical characteristics of 
HIV-infected individuals in Bahia
Features All patients
 (n = 147)
Age, mean 45 (24-68)
Sex 
Male (%) 60.1
Female (%) 39.9
Risk of HIV infection 
Homosexual (%) 19.6
Heterosexual (%) 65.2
Blood transfusion(%) 3.1
IDV (%) 3.9
Bisexual (%) 7.6
Unknown (%) 7.6
CD4+ T cell count (cells/m3), mean ± SD 303 ± 228
Viral load (copies/mL), mean±SD 107,841 ± 198,925
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Statistical analysis
Mean viral load and CD4+ T cells count for each patient (be-
fore starting antiretroviral therapy) was estimated and used 
as representative value in the statistical analysis. ANOVA and 
Mann-Whitney tests were used to compare continuous vari-
ables. Fisher’s exact test was used to investigate associations 
between categorical variables and correction for multiple 
tests was applied when necessary. Hardy-Weinberg Equilib-
rium analysis was performed for each population (control-
lers and non-controllers of viremia) using Genepop soft-
ware.31 Additionally, Odds Ratio (OR), and their 95% 
confidence interval was used to determine the strength 
of the allele-specific associations that were statistically 
significant.
RESULTS
We detected a direct correlation between viral load and CD4+ 
T cell count, fundamental markers for HIV-infected pa-
tient monitoring. It was statistically signifi cant (R = -0.307; 
p < 0.001, by Pearson´s correlation) and the regression anal-
ysis suggested there was a logarithmic relationship between 
both variables.
Effects of HLA-Bw4 on viral load and CD4+ T cell 
count modulation
Viral load averages for Bw4, Bw4/Bw6 and Bw6 pheno-
types are shown in Figure 1, which emphases the increasing 
Table 2. Bw4 and Bw6 epitopes and their corresponding alleles observed in the HIV-infected individuals in Bahia
Serological Amino-acid     Corresponding alleles
epitope at position
 77 80 81 82 83 
Bw4 Asn Ile Ala Leu Arg B*1516 B*1517 B*1524 B*3801   
      B*4901 B*51
      B*5201 B*53B* 57 B*58 A*23 A*24
 Asn Thr Ala Leu Arg B*13 B*44
 Asp Thr Leu Leu Arg B*2703 B*2713 B*3701
 Ser Ile Ala Leu Arg A*32
Bw6 Ser Asn Leu Arg Gly B*07 B*0801 B*1401 B*1402 B*1501 B*1502
      B*1503 B*1504 B*1507 B*1510 B*1520 
      B*1554 B*1801 B*1820 B*35 B*39 B*4001 
      B*4001 B*41 B*42 B*4501 B*5001 B*55 B*8101
Figure 1: HLA-Bw4 presence associated with low levels of plasmatic viral load. Viral load average was calculated for 147 
HIV-infected individuals and is shown on the top of the respective bars.
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gradient from absence of HLA-Bw6 to presence of 
HLA-Bw4. ANOVA test showed a borderline signifi cant dif-
ference between and within the groups that was lost after 
correction (p = 0.059; pc = 0.076) (Table 3). The categoriza-
tion into Bw4+ (Bw4/Bw/4 and Bw4/Bw6) and Bw4- (Bw6/
Bw6) patients groups yielded a more signifi cant association. 
Mann-Whitney test revealed a statistically signifi cant differ-
ence between Bw4+ and Bw4- groups, suggesting an associa-
tion of the presence of HLA-Bw4 with viral load reduction 
(Z = -2.052; p = 0.040) (Table 3). Additionally, we observed 
that 18 out of the 147 HIV-infected individuals presented 
viremia ≤ 1,800 copies/mL and 129 presented viremia 
> 2,000 copies/mL. Ninety four percent (17/18) of all indi-
viduals with viremia ≤ 1,800 copies/mL carried HLA-Bw4, 
compared to 67.4% (87/129) of individuals with viremia 
> 2,000 copies/mL (Table 4). We detected a statistically 
signifi cant association (OR = 8.21; 95% CI = 1.08-63.76; 
p = 0.018; Fisher´s exact test) between the presence of 
HLA-Bw4 and low levels of viremia.
The same comparative analysis used for viral load 
was used for CD4+ T cell count average (Figure 2). Al-
though individuals presenting Bw4+ had a higher mean 
CD4+ T cell count than individuals not presenting this 
allele, the comparison of the groups revealed no signifi-
cant association between the presence of HLA-Bw4 and 
higher CD4+ T cell count (p = 0.282), even after strati-
fying patients into Bw4+(Bw4/Bw/4 and Bw4/Bw6) and 
Bw4- (Bw6/Bw6) groups (Z = 1.220; p = 0.222) (Table 
3), suggesting no influence of HLA-Bw4 on CD4+ T cell 
count modulation.
Table 3. Genetic factors associated with clinical markers in HIV-infected patients without antiretroviral therapy
Genotype Patients
 (n = 147) 
Clinical markers
  
Clinical markers
  
  aCD4+ count,  bp aViral Load, bp cpc
  cells/mm3 value RNA copies/mL value value
HLA Bw4/Bw4 26 (17.7) 363 (233) 0.282 57,849 (81,414) 0.059 0.076
HLA Bw4/Bw6 78 (53.1) 295 (226)  109,266 (221,885)  
HLA Bw6/Bw6 43 (29.2) 282 (227)  135,484 (202,527)  
Bw4+(Bw4/Bw4;Bw4/Bw6) 104 (70.7) 315 (228) 0.222 96,411 (197,268) 0.040 
Bw4-(Bw6/Bw6) 43 (29.2) 282 (227)  135,484 (202,527)
Bw4+ non-B*27 102 (69.4) 317 (230) 0.698 84,115 (147,066) 0.044 
Bw4+ non-B*57 89 (60.5) 312 (230) 0.781 93,523 (153,732) 0.201 
Bw4+ non-B*27 non-B*57 87 (59.2) 315 (231) 0.721 93,990 (154,644) 0.194 
Bw4+-Ile80+ 80 (76.9) 319 (240) 0.792 105,455 (219,144) 0.966 
Bw4+-Ile80- 24 (23.1) 288 (184)  66,297 (89,930)  
KIR3DL1 107 (72.8) 303 (233) 0.875 104,035 (163,404) 0.360 
KIR3DS1 32 (21.8) 297 (199)  141,678 (303,066)  
dNon KIR3DL1-3DS1 08 (5.4) 376 (279)  16,054 (21,926)  
KIR3DL1+Bw4+ Ile80+ 62 (59.6) 320 (243) 0.923 92,632 (171,015) 0.354 0.934
KIR3DL1+Bw4+ Ile80- 15 (14.4) 303 (193)  86,802 (108,495)  
KIR3DS1+Bw4+ Ile80+ 19 (18.3) 302 (215)  183,544 (362,791)  
KIR3DS1+Bw4+ Ile80- 08 (7.7) 265 (176)  44,174 (51,328)  
aMean ± SD; bp values were computed using Mann-Whitney, ANOVA and the χ2 Tests. cpc values were computed using Kruskal-
Wallis Test. dNon considered in the analysis.
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Figure 2: HLA-Bw4 presence associated with high levels of CD4+ T cell count. CD4+ T cell count average was calculated for 147 
HIV-infected individuals and is shown on top of the respective bars.
Table 4. HLA and KIR genotype in 147 HIV-1 infected patients according to control of viremia
Genotype Controller of viremia (n/%) Non-controller of viremia (n/%) p
 (n = 18) (n = 129) valuea 
OR (95% CI)
HLA Bw4/Bw4 04 (22.2) 22 (17.0) 0.020 
HLA Bw4/Bw6 13 (72.2) 65 (50.4)  
HLA Bw6/Bw6 01 (5.5) 42 (32.5)  
Bw4+(Bw4/Bw4;Bw4/Bw6) 17 (94.4) 87 (67.4) 0.018 8.21 (1.08-63.76)
Bw4-(Bw6/Bw6) 01 (5.5) 42 (32.5)  
Bw4+-Ile80+ 13 (76.5) 67 (77.0) 0.790 0.97 (0.28-3.31)
Bw4+-Ile80- 04 (23.5) 20 (23.0)  
KIR3DL1 14 (77.8) 93 (72.1) 0.287 2.26 (0.49-10.51)
KIR3DS1 02 (11.1) 30 (23.2)  
bNon 3DL1+-3DS1+ 02 (11.1) 06 (4.6)  
KIR3DL1+Bw4+ Ile80+ 11 (64.7) 48 (55.2) 0.313 
KIR3DL1+Bw4+ Ile80- 02 (11.7) 12 (13.8)  
KIR3DS1+Bw4+ Ile80+ 01 (5.9) 15 (17.2)  
KIR3DS1+Bw4+ Ile80- 01 (5.9) 06 (6.9)  
bNon 3DL1+-3DS1++Bw4+ 02 (11.7) 06 (6.9)  
Loci/allele    
HLA-A - - 0.828 
HLA-B    
B*27 1 (5.5) 1 (0.8) 0.100 7.53 (0.45-126.02)
B*57 8 (44.4) 7 (5.4) < 0.0001 13.94 (4.19-46.38)
HLA-C    
Cw*18 05 (27.8) 03 (2.3) < 0.0001 16.15 (3.46-75.43)
Note: OR, Odds ratio; CI, confidence interval.ap values were computed using Fisher’s exact test; bNon considered in the analysis.
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Protective B*57 and Cw*18 alleles in the viremia 
controller
HLA class I alleles play a role in the biology of both NK and 
CTL responses, in the control of viral load levels. To evalu-
ate the inﬂ uence of HLA class I alleles in viremia control we 
compared the frequencies of HLA-A, HLA-B, and HLA-C al-
leles for viremia controller and non-controller groups. No 
signifi cant deviations from Hardy-Weinberg equilibrium 
were found in all loci analyzed: HLA-A (p = 0.33), HLA-B 
(p = 0.34), and HLA-C (p = 0.30). No statistically signifi -
cant difference for HLA-A allele frequencies was found be-
tween the groups (p = 0.828) (Table 4). However, we de-
tected a signifi cant difference in the B*57 (OR = 13.94; 95% 
CI = 4.19-46.38; p < 0.0001) and Cw*18 (OR = 16.15; 95% 
CI = 3.46-75.43; p < 0.0001) allele frequencies, which were 
relatively more frequent in the viremia controller than in 
non-controller group (Table 4). These data suggest a protec-
tive role of the B*57 and Cw*18 alleles in the control of viral 
load. Curiously, 100% of Cw*18 carriers (5/5) that control 
the viremia are also B*57 carriers, while this last allele was 
found in 66.7% (2/3) of the non-controller group.
Inﬂ uence of HLA-B*57 allele in the protection 
conferred by HLA-Bw4
Genetic and functional studies have shown a protective ef-
fect of HLA class I alleles, in particular B*27 and B*57, in the 
HIV disease progression. These alleles belong to the HLA-B 
Bw4 group. In order to evaluate the effects on NK and CTL 
responses to that regard, we analyzed the role of HLA-Bw4 
on HIV disease progression markers in the presence and 
absence of B*27 and B*57 alleles. The protective effect of 
HLA-Bw4 remained signifi cantly upon removal of the indi-
vidual positive for B*27 (p = 0.044), but was entirely lost in 
the absence of B*57 (p = 0.201) (Table 3), indicating that the 
protection conferred by HLA-Bw4 is completely dependent 
on the presence of B*57.
Effects of KIR3DS1/3DL1 on viral load and CD4+ T 
cell count modulation
HLA-Bw4 molecules with isoleucine at position 80 (Bw4-
80Ile) are ligands for inhibitory KIR3DL1 receptors and 
Bw4-80Ile in combination with the activating KIR3DS1 
found to result in delayed progression to AIDS. To assess the 
effect of the alleles Bw4-80Ile, KIR3DL1 and KIR3DS1 on viral 
load and CD4+ T cell count modulation we analyzed their dis-
tribution in this population. Initially, we compared the viral 
load and CD4+ T cell average between the patients Bw4-80Ile+ 
(80Ile/80Ile or 80Ile/80Thr) and Bw4-80Ile- (80Thr/80Thr) 
(Table 3). We observed a non protective inﬂ uence of 
Bw4-80Ile on viral load (p = 0.687) or CD4+ T cell count 
(p = 0.687) modulation. Next, we compared the frequencies 
of Bw4-80Ile and Bw4-80Thr in the viremia controllers and 
non-controllers groups (Table 4). We found no statistically 
signifi cant difference between the groups (p = 0.790). This 
result may suggest that the association of HLA-Bw4 with vi-
ral load reduction in the HIV-1 infection found here is not 
specifi cally attributed to the Bw4-80Ile. The inﬂ uence of 
KIR3DL1 and KIR3DS1 subtypes on clinical markers modu-
lation was also tested: KIR3DL1 and KIR3DS1 were carried 
by 72.8% (107/147) and 21.8% (35/147) of patients, respec-
tively. Eight patients (5.4%) who were negative for KIR3DL1 
and KIR3DS1 were not included in the analysis (Table 3). We 
did not fi nd any signifi cant association between the presence 
or absence of KIR3DL1/KIR3DS1 genotype and the clinical 
markers of HIV-1 infection (Tables 3 and 4). We observed 
that all patients who carried protective B*57 and Cw*18 
(B*57 = 15/147; B*57-Cw*18 = 7/15; Cw*18 = 8/147) alleles 
also carried KIR3DL1, but carried no KIR3DS1. These data 
suggest no effect of KIR3DS1/3DL1 genotype on viral load 
and CD4+ T cell count modulation.
DISCUSSION
Previous fi ndings have shown the important role of cel-
lular immunity in controlling HIV-1 replication.8,10,11,32 
HIV-specifi c CTL, selected according to HLA class I reper-
toire associated to viral peptides, can control the viral rep-
lication effi ciently through lysis of infected cells before new 
viral particles arise.14 In this study HLA-A and HLA-B alleles 
were grouped according to serological antigens HLA-Bw4 
and HLA-Bw6 (Table 2). Some studies have reported the im-
portant inﬂ uence of HLA-Bw4 in HIV-1 pathogenesis. Mar-
tin et al (2002) demonstrated epistatic interaction between 
KIR3DS1/Bw4-80Ile and delayed progression to AIDS by 
genetic analysis.21 Qi et al have demonstrated that KIR3DS1/
Bw4-80Ile genotype is involved directly in the protection 
against HIV-1, controlling the viral load through lysis of 
infected cells, and/or indirectly preventing or delaying the 
onset of opportunistic infections.24 This corroborates our 
fi ndings.
Here, we observed an association between HLA-Bw4 
and viral load reduction. The HLA-Bw4 phenotype seems to 
modulate the viral load levels, when considering the whole in-
fected population (Figure 1 and Table 3). Ninety four percent 
of these patients, who consistently presented viral load levels 
≤ 1,800 copies/mL, during a period of 2 to 12 years without 
antiretroviral therapy, carried HLA-Bw4, which confi rms the 
protective role of this specifi c allele for HIV-infected individ-
uals. However, the protective inﬂ uence of HLA-Bw4 on the 
control of viremia is completely dependent on the presence 
of B*57 allele (Table 3), a fi nding that confi rm the already re-
ported favorable effect of B*57 on HIV-1 viral load.6
Beyond the B*27 and B*57, HLA-C alleles can play an 
important role in the HIV/AIDS context. Lazaryan et al have 
demonstrated that Cw*18 allele is associated with lower 
viral load among all subjects with and without B*5703 in 
the Zambian cohort.33 In our study, 27.8% of the viremia 
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controllers individuals carried Cw*18 allele, which was sig-
nifi cantly associated with lower viral load levels, suggesting 
a protector effect on HIV-1 infection in this population. As 
100% (5/5) of controllers of viremia individuals who car-
ried Cw*18 also carried B*57 and these alleles are in linkage 
disequilibrium it is possible to attribute the protective effect 
of Cw*18 to the presence of B*57. Theoretically, the role of 
Cw*18 and HLA-Bw4/B*57 may be independent, although it 
can be involved in the same context to produce effective NK 
and CTL responses.
HLA-Bw4 epitope and HLA-C allotypes are ligands for 
NK cell receptors KIR3DL1/3DS1 and KIR2DL1/2DL2/2DL3, 
respectively34 and stimulate its cytotoxic activity that is com-
plementary to CTL responses. Inhibitory KIR3DL1 and ac-
tivating KIR3DS1 receptors can play a protective effect on 
AIDS progression in the presence of HLA Bw4-80Ile ligand 
in the infected cell.21,35 Inhibitory KIR3DL1 allele highly ex-
pressed on the cell enhance protection conferred by HLA 
Bw4-80Ile allele, including B*57 specifi cally.35 In our work 
HLA Bw4-80Ile, KIR3DL1 and KIR3DS1 alleles had no inﬂ u-
ence in the modulation of clinical markers in HIV-1 infec-
tion, even in face of high KIR3DL1 (72.8%) and moderate 
KIR3DS1 (21.8%) expression.
Involvement of Cw*18 in NK cell activity will not be 
discussed here because we did not verify the distribution of 
KIR2DL(1-3) receptors to HLA-C allotypes, and therefore it 
is beyond the scope of this work. We cannot defi ne the exact 
mechanism by means both populations of T lymphocytes 
(CTL and NK) might modulate the virus level in favor of 
the host. However, once the pivotal role of CTL is inﬂ uenced 
by the HLA profi le, we could suggest that the allelic groups 
of HLA-B that compound the HLA-Bw4 group and HLA-
Cw*18 allele are specifi c and more effi cient in presenting 
peptides of circulating viral variants in this population, be-
ing able to produce an effective cellular immune responses. 
In addition, according to our results, it is possible to suggest 
that HLA-Bw4 and HLA-Cw*18 might function as activa-
tors of NK cell cytotoxic activity to destroy HIV-infected 
cells, which represent one of the main viral reservoirs. As a 
consequence of the destruction of these reservoirs mediated 
by combined CTL and NK activity, the plasmatic viral levels 
would decrease. Obviously, functional assays would be nec-
essary to confi rm this hypothesis.
Our data not only confi rm the fi ndings of other stud-
ies, in different populations, but also reinforce the impor-
tant inﬂ uence of the MHC polymorphisms in HIV/AIDS 
natural history, regardless the ethnic groups. It is very im-
portant to emphasize that the Brazilian urban populations 
are quite heterogeneous in terms of ethnic/genetic structure, 
and unique (a wide genetic mixture involving Amerindians, 
Portuguese and Africans),26-28,36 when compared to other 
populations around the world. Bahia, in particular, has a 
bigger genetic contribution of Africans and Portuguese,26-28 
what becomes genetically different of the populations from 
other regions of Brazil. Additionally, environmental factors 
involved in HIV infection, such as social-economic and cul-
tural factors, are also particular to this specifi c Brazilian re-
gion (Bahia), which resembles African countries, not only 
due to its genetic composition but also to social structure, 
culture, and health problems.28,37 Therefore, we could de-
duce that the profi le of the association found here will be 
able to serve as orientation foretells for politics of public 
health, with reference to infection/illness prevention, and 
that the HLA profi le of the studied patients can be used for 
therapeutic monitoring in order to improve the effectiveness 
of the AIDS treatment.
CONCLUSIONS
HLA-Bw4-B*57 and Cw*18 alleles are associated with lower 
level of viral load in HIV-infected patients from Bahia. This 
is the fi rst study to demonstrate that serological epitopes 
HLA-Bw4 and HLA class I alleles are associated with disease 
progression markers in HIV-1 infection involving patients 
from Bahia, and provides important information about how 
the host genetic factors inﬂ uence the AIDS clinical course.
Taken together, these fi ndings may help us in under-
standing the determinants of HIV evolution in Brazilian 
patients, as well as in providing important information on 
immune response correlates of protection for such popula-
tion. The prevention of the AIDS development in the Bahia 
population will reduce the costs with medicines that are nec-
essary for who has already developed the disease. However, 
it is necessary to confi rm these data through a study with a 
larger number of samples.
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